Tepnel buys Orchid Biosciences

Happy New Year everyone

Looks like the New Year should start well for TED shareholders. Lots of promising news to be expected throughout the first period and the share price support seems to have bottomed out at 11.5p and is starting to reverse.

News to be expected
-------------------------------
- annual results
- Orchid Diagnostics aquisition update
- further aquisition or two (as long as NO MORE discounted share issues)?
- further sales of T2000s. Especially in America.
- progress and likely future demand of T3000
- Seymour's broker research note (please note, there has not been any broker notes out for several years now).
- Peanut Allergy commercial launch and sales
- etc.

Note recent director sharedealing
-------------------------------------------------
Craig (Chairman) 4/12/03 174K - £20K - 11.5p
Matzilevich (Chief Exec) 27/11/03 - 435K - £50K - 11.5p
Ffoulkes-Davies (FD) 27/11/03 250K - £28,800 - 11.5p
Ffoulkes-Davies (FD) 8/8/03 134K - £21,400 - 16p
Ffoulkes-Davies (FD) 27/11/03 250K - £34,800 - 14p

Other older director sharedealings still held, but much smaller in size. IMHO shows confidence in the company.

Total shareholding in company
-----------------------------------------------
Craig (Chairman) 207K 0.15%
Matzilevich (Chief Exec) 935K 0.71%
Ffoulkes-Davies (FD) 650K 0.49%

Recent Trading volumes
-------------------------------------------
tot buys tot sells tot unknown
31/12 386,358 4,791 0
30/12 154,523 61,116 0
29/12 550,169 1,085 0
24/12 0 42,500 0
23/12 85,548 12,500 50,000
22/12 836,673 282,733 0
19/12 14,402 49,832 0
18/12 10,000 200,686 0
17/12 246,961 16,564 0
16/12 94,266 92,939 8,000
15/12 42,207 417,983 200,000
12/12 265,569 115,461 0

Looking for 16p+ by end of Jan / beg Feb if this reversal continues, and this is just the beginning.